Date published: 2026-5-12

1-800-457-3801

SCBT Portrait Logo
Seach Input

FBXO6 Inhibitors

FBXO6 inhibitors belong to a specialized class of chemical compounds that have garnered significant attention in the field of molecular biology and cellular protein degradation mechanisms. FBXO6, or F-Box Protein 6, is a component of the Skp1-Cul1-F-box protein (SCF) ubiquitin ligase complex, which plays a crucial role in tagging specific target proteins for degradation via the ubiquitin-proteasome pathway. FBXO6 inhibitors is a group of molecules meticulously designed to selectively target and modulate the activity of FBXO6. These inhibitors serve as invaluable tools in laboratory investigations, enabling researchers to explore the intricate molecular functions and cellular processes associated with FBXO6. FBXO6 inhibitors typically function by interfering with the interaction between FBXO6 and its substrate proteins, preventing their ubiquitination and subsequent degradation. This interference can lead to the stabilization of target proteins and potentially impact various cellular processes that rely on precise protein turnover. Researchers employ FBXO6 inhibitors to gain insights into the physiological roles and molecular interactions of FBXO6 within cells, aiming to advance our understanding of the fundamental mechanisms involved in protein quality control, cellular homeostasis, and the regulation of specific cellular pathways. Through the study of FBXO6 inhibitors, scientists seek to unravel the complexities of protein degradation, post-translational modifications, and the broader field of molecular and cellular biology, contributing to our knowledge of how cells regulate the abundance and activity of key proteins to maintain their functionality and adapt to changing conditions.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Betulinic Acid

472-15-1sc-200132
sc-200132A
25 mg
100 mg
$117.00
$344.00
3
(1)

Betulinic Acid might alter FBXO6 levels by influencing nuclear factor-kB (NF-kB) signaling, which can modulate gene expression patterns.

Withaferin A

5119-48-2sc-200381
sc-200381A
sc-200381B
sc-200381C
1 mg
10 mg
100 mg
1 g
$130.00
$583.00
$4172.00
$20506.00
20
(1)

Withaferin A is known to inhibit the proteasomal pathway, potentially affecting the turnover of F-box proteins such as FBXO6.

Homoharringtonine

26833-87-4sc-202652
sc-202652A
sc-202652B
1 mg
5 mg
10 mg
$52.00
$125.00
$182.00
11
(1)

Homoharringtonine can inhibit protein synthesis translationally, potentially reducing FBXO6 protein levels.

Celastrol, Celastrus scandens

34157-83-0sc-202534
10 mg
$158.00
6
(1)

Celastrol affects heat shock proteins and could influence FBXO6 expression via stress-induced signaling pathways.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

Disulfiram can modulate proteasome activity, which might indirectly impact the expression or stability of FBXO6.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein, a tyrosine kinase inhibitor, might indirectly affect FBXO6 expression by altering cellular signaling pathways.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Quercetin can inhibit PI3K and other kinases, potentially leading to changes in FBXO6 expression.

Ivermectin

70288-86-7sc-203609
sc-203609A
100 mg
1 g
$57.00
$77.00
2
(2)

Ivermectin, by altering ion transport and cellular signaling, might influence FBXO6 expression indirectly.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

Geldanamycin binds to heat shock protein 90 (Hsp90) and might affect the stability of client proteins, possibly including FBXO6.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that might affect FBXO6 expression through changes in AKT signaling pathways.